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Vulvar cancer is rare, mostly afflicting women aged 60 
and older [1]. The cancer is often preceded by a 
common vulvar rash, Lichen sclerosis, that is often 
treated with the ultra-potent corticosteroid, clobetasol 
propionate. This treatment may, in turn, be associated 
with vulvar carcinogenesis. Our previous findings 
suggest that initial clobetasol exposure can result in a 
state of quiescence in UMSCV-4 cells and that long term 
clobetasol exposure selects for cell subpopulations that 
are unable to re-enter quiescence upon clobetasol 
re-exposure [5]. Quiescence is a temporary removal 
from the cell cycle and can be thought of as a dormant 
state in which cells are not actively dividing [2]. There is 
growing evidence suggesting that quiescence may play 
a role in allowing cancer cells to contribute to the 
recurrence of the cancer months or years after treatment 
[3]. There are several cell cycle inhibitors that may 
indicate quiescence, including p16, p21, p53, and p27 
[4]. Preliminary studies in our lab suggest that p16, p21, 
and p53 do not play a clear role in clobetasol-induced 
quiescence of UMSCV-4 cells. The role of p27 in 
quiescence of UMSCV-4 cells also does not appear to 
be straightforward, and further studies confirming these 
results and exploring other signaling pathways related to 
quiescence are necessary. 
INTRODUCTION
MATERIALS & METHODS
                                                                                                                                                                                                                                                                             
❏ We would expect NT cells exposed to clobetasol to upregulate cell 
cycle inhibitors, since these cells are temporarily growth arrested 
when exposed to clobetasol [5]. There does not appear to be a 
clear correlation between the upregulation of the cell cycle 
inhibitors, p16, p21, p53, and p27 upon initial clobetasol exposure 
in NT cells.
❏ We would expect LT cells exposed to clobetasol to downregulate 
cell cycle inhibitors, as we have previously demonstrated these 
cells appear unable to re-enter quiescence [5]. There does not 
appear to be a clear correlation between the downregulation of the 
cell cycle inhibitors, p16, p21, p53, and p27 upon clobetasol 
re-exposure in LT cells. 
❏ It is possible that the aforementioned cell cycle inhibitors do not 
play a role in UMSCV-4 cell quiescence, as previous studies have 
demonstrated quiescence can relieve the requirement for Notch 
signaling in certain cell types [6]. Quiescence could also relieve the 
requirement for p16, p21, p53, and p27 inhibitors, and this could 
explain our otherwise unexpected results. 
CONCLUSION
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FURTHER STUDIES
❏ Further research will focus on repeating RT-PCR examining p16, p21, 
p53, and p27 expression, as we need to have a larger number of 
trials in order to determine statistical significance of our results.
❏ Further research will study the role of Notch signaling in clobetasol 
treated NT and LT cells. If our results are consistent with previous 
studies examining Notch signaling in quiescent cells, it is possible 
that quiescence relieves the requirement for both Notch signaling and 
the cell cycle inhibitors we studied [6]. 
Cells were examined for changes in mRNA expression of key markers 
indicative of entering a state of quiescence via RT-PCR. Clobetasol was 
diluted in 95% ethanol (10-7 M  final concentration) and UMSCV-4 cells 
were cultured in the presence (+clob) or absence of clobetasol (-clob 
+EtOH) for these experiments.  UMSCV-4 LT cell populations were 
generated as described in Figure 1.
The basic procedure for examination of clobetasol effects on UMSCV-4 NT 
and UMSCV-4 LT cells was as follows
❏ EtOH 10d: Ethanol treated (same concentration as would be found for 
the clobetasol containing medium) for 10 days 
❏ Clob10d: Treated with clobetasol for 10 days 
❏ Clob 6d-4d: Treated with clobetasol for 6 days and changed to ethanol 
containing medium for 4 days 
❏ Cells from each group were subsequently harvested and tested using 
protocols described in each figure. 
CONCLUSIONS
Figure 1.  Re-exposure of UMSCV-4 cells to clobetasol results in resistance to the 
growth inhibition effects of clobetasol. This model represents the process that led to 
generation of the long-term, clobetasol “resistant” UMSCV-4 cells.  Untreated UMSCV-4 
cells were exposed to clobetasol for 3 months during which time the clobetasol medium 
was refreshed periodically to account for evaporation but the cells were not removed or 
passaged.  After 3 months the clobetasol was removed and cells were allowed to 
“recover” for 4 weeks in medium not containing ethanol or clobetasol.  Note that mitotic 
cells were visible within 3 days of clobetasol removal.  After 4 weeks proliferating cells 
were re-exposed to clobetasol.  These cells did not experience the growth arrest seen 
when originally exposed to clobetasol.  This population of cells is referred to as 
UMSCV-4 LT. 
Figure 2. UMSCV-4 untreated cells (no treatment) show a decrease in 
proliferation and changes in morphology when treated with clobetasol 
while the long-term cells (see Figure 1) showed little change in growth rate 
or morphology.  UMSCV-4 untreated cells (NT) or long-term (LT) were exposed 
to clob for 10 days (+clob 10 day, panels A and D) or to clob for 6 days followed 
by treatment with ethanol for a subsequent 4 days (+clob 6 day, 4 day, panels B 
and E) or to vehicle alone for the full 10 days (+EtOH, panels C and F).  Clob 
treatment of the untreated cells caused the cell morphology to become more 
neuronal-like and many of the cells became vacuolated (panel A).  The growth 
rate also decreased [5].  When the cells were treated for 6 days and then 
removed from clob the cells did not recover their normal morphology (panel B) 
but several patches of mitotic cells began to appear at day 4 post treatment [5].  
Cells that were grown in the presence of vehicle (+EtOH, panel C) did not show 
any morphological changes nor growth arrest.  The LT cells grew at basically the 
same rates whether in clob for 10 days (panel D), clob for 4 days followed by 
EtOH only (panel E) or in EtOH for the full 10 days (panel F).  Total RNA was 
extracted from these cells and used for subsequent RT-PCR as described in 
subsequent figures.   
RESULTS
Figure 4. Cell cycle inhibitor, p27, does not appear to play a direct role in 
clobetasol-induced quiescence in UMSCV-4 cells, although it is slightly upregulated 
after 10 days exposure to clobetasol in NT cells. A) RT-PCR gene expression analysis 
of p27 in clobetasol treated NT cells. B) RT-PCR gene expression analysis of p27 in 
clobetasol treated LT cells. We would expect the levels of the p27 to be upregulated upon 
initial clobetasol exposure in NT cells that typically enter quiescence, and downregulated in 
LT cells that are typically unable to re-enter quiescence. Initial results do not demonstrate 
this relationship or any other clear relationship between the regulation of these inhibitors 
and clobetasol exposure.  
Figure 3. Cell cycle inhibitors p16, p21, and p53 do not appear to play a direct role 
in clobetasol-induced UMSCV-4 cell quiescence. A) RT-PCR gene expression 
analysis of p16, p21, and p53 in clobetasol treated NT cells. B) RT-PCR gene 
expression analysis of p16, p21, and p53 in clobetasol treated LT cells. We would 
expect the levels of the aforementioned cell cycle inhibitors to be upregulated upon 
initial clobetasol exposure in NT cells that typically enter quiescence, and 
downregulated in LT cells that are typically unable to re-enter quiescence. Initial results 
do not demonstrate this relationship or any other clear relationship between the 
regulation of these inhibitors and clobetasol exposure. 
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